Haemonetics Corporation
General ticker "HAE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $4.2B
Haemonetics Corporation follows the US Stock Market performance with the rate: 9.6%.
Estimated limits based on current volatility of 1.9%: low 75.26$, high 78.11$
Factors to consider:
- US accounted for 72.1% of revenue in the fiscal year ended 2023-04-01
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-30 to 2026-03-30
- 2024-03-30 to 2025-03-30 estimated range: [66.79$, 99.49$]
- 2025-03-30 to 2026-03-30 estimated range: [75.64$, 110.59$]
Financial Metrics affecting the HAE estimates:
- Positive: Non-GAAP EPS, $ of 3.98 > 2.29
- Positive: 9.05 < Operating profit margin, % of 12.60
- Negative: 0 < Industry inventory ratio change (median), % of 0.06
- Negative: Industry earnings per price (median), % of -6.33 <= 1.31
- Positive: Interest expense per share, $ of 0.26 <= 0.74
- Negative: Industry operating profit margin (median), % of -25.26 <= 2.14
Short-term HAE quotes
Long-term HAE plot with estimates
Financial data
| YTD | 2022-04-02 | 2023-04-01 | 2024-03-30 |
|---|---|---|---|
| Operating Revenue | $1,002.80MM | $1,169.04MM | $1,309.06MM |
| Operating Expenses | $922.05MM | $1,013.01MM | $1,144.17MM |
| Operating Income | $80.75MM | $156.03MM | $164.88MM |
| Non-Operating Income | $-17.12MM | $-14.63MM | $-13.02MM |
| Interest Expense | $17.12MM | $14.63MM | $13.02MM |
| R&D Expense | $46.80MM | $50.13MM | $54.44MM |
| Income(Loss) | $63.63MM | $141.40MM | $151.87MM |
| Taxes | $20.25MM | $26.00MM | $34.31MM |
| Profit(Loss) | $43.38MM | $115.40MM | $117.56MM |
| Stockholders Equity | $749.42MM | $818.00MM | $959.96MM |
| Inventory | $293.03MM | $259.38MM | $317.20MM |
| Assets | $1,859.73MM | $1,934.83MM | $2,195.59MM |
| Operating Cash Flow | $172.26MM | $273.06MM | $181.75MM |
| Capital expenditure | $96.51MM | $110.19MM | $66.30MM |
| Investing Cash Flow | $-86.34MM | $-143.79MM | $-322.39MM |
| Financing Cash Flow | $-15.75MM | $-100.36MM | $38.16MM |
| Earnings Per Share* | $0.85 | $2.27 | $2.32 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.